Cargando…

Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway

Patients with cancer who receive doxorubicin (DOX) treatment can experience cardiac dysfunction, which can finally develop into heart failure. Oxidative stress is considered the most important mechanism for DOX-mediated cardiotoxicity. Rutaecarpine (Rut), a quinazolinocarboline alkaloid extracted fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Zi-Qi, Jiang, Yi-Nong, Su, Zhuo-Lin, Bi, Hai-Lian, Li, Jia-Tian, Li, Cheng-Lin, Yang, Xiao-Lei, Zhang, Ying, Xie, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766983/
https://www.ncbi.nlm.nih.gov/pubmed/35071368
http://dx.doi.org/10.3389/fcvm.2021.809689
_version_ 1784634627981312000
author Liao, Zi-Qi
Jiang, Yi-Nong
Su, Zhuo-Lin
Bi, Hai-Lian
Li, Jia-Tian
Li, Cheng-Lin
Yang, Xiao-Lei
Zhang, Ying
Xie, Xin
author_facet Liao, Zi-Qi
Jiang, Yi-Nong
Su, Zhuo-Lin
Bi, Hai-Lian
Li, Jia-Tian
Li, Cheng-Lin
Yang, Xiao-Lei
Zhang, Ying
Xie, Xin
author_sort Liao, Zi-Qi
collection PubMed
description Patients with cancer who receive doxorubicin (DOX) treatment can experience cardiac dysfunction, which can finally develop into heart failure. Oxidative stress is considered the most important mechanism for DOX-mediated cardiotoxicity. Rutaecarpine (Rut), a quinazolinocarboline alkaloid extracted from Evodia rutaecarpa was shown to have a protective effect on cardiac disease. The purpose of this study is to investigate the role of Rut in DOX-induced cardiotoxicity and explore the underlying mechanism. Intravenous injection of DOX (5 mg/kg, once a week) in mice for 4 weeks was used to establish the cardiotoxic model. Echocardiography and pathological staining analysis were used to detect the changes in structure and function in the heart. Western blot and real-time PCR analysis were used to detect the molecular changes. In this study, we found that DOX time-dependently decreased cardiac function with few systemic side effects. Rut inhibited DOX-induced cardiac fibrosis, reduction in heart size, and decrease in heart function. DOX-induced reduction in superoxide dismutase (SOD) and glutathione (GSH), enhancement of malondialdehyde (MDA) was inhibited by Rut administration. Meanwhile, Rut inhibited DOX-induced apoptosis in the heart. Importantly, we further found that Rut activated AKT or nuclear factor erythroid 2-related factor 2 (Nrf-2) which further upregulated the antioxidant enzymes such as heme oxygenase-1 (HO-1) and GSH cysteine ligase modulatory subunit (GCLM) expression. AKT inhibitor (AKTi) partially inhibited Nrf-2, HO-1, and GCLM expression and abolished the protective role of Rut in DOX-induced cardiotoxicity. In conclusion, this study identified Rut as a potential therapeutic agent for treating DOX-induced cardiotoxicity by activating AKT.
format Online
Article
Text
id pubmed-8766983
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87669832022-01-20 Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway Liao, Zi-Qi Jiang, Yi-Nong Su, Zhuo-Lin Bi, Hai-Lian Li, Jia-Tian Li, Cheng-Lin Yang, Xiao-Lei Zhang, Ying Xie, Xin Front Cardiovasc Med Cardiovascular Medicine Patients with cancer who receive doxorubicin (DOX) treatment can experience cardiac dysfunction, which can finally develop into heart failure. Oxidative stress is considered the most important mechanism for DOX-mediated cardiotoxicity. Rutaecarpine (Rut), a quinazolinocarboline alkaloid extracted from Evodia rutaecarpa was shown to have a protective effect on cardiac disease. The purpose of this study is to investigate the role of Rut in DOX-induced cardiotoxicity and explore the underlying mechanism. Intravenous injection of DOX (5 mg/kg, once a week) in mice for 4 weeks was used to establish the cardiotoxic model. Echocardiography and pathological staining analysis were used to detect the changes in structure and function in the heart. Western blot and real-time PCR analysis were used to detect the molecular changes. In this study, we found that DOX time-dependently decreased cardiac function with few systemic side effects. Rut inhibited DOX-induced cardiac fibrosis, reduction in heart size, and decrease in heart function. DOX-induced reduction in superoxide dismutase (SOD) and glutathione (GSH), enhancement of malondialdehyde (MDA) was inhibited by Rut administration. Meanwhile, Rut inhibited DOX-induced apoptosis in the heart. Importantly, we further found that Rut activated AKT or nuclear factor erythroid 2-related factor 2 (Nrf-2) which further upregulated the antioxidant enzymes such as heme oxygenase-1 (HO-1) and GSH cysteine ligase modulatory subunit (GCLM) expression. AKT inhibitor (AKTi) partially inhibited Nrf-2, HO-1, and GCLM expression and abolished the protective role of Rut in DOX-induced cardiotoxicity. In conclusion, this study identified Rut as a potential therapeutic agent for treating DOX-induced cardiotoxicity by activating AKT. Frontiers Media S.A. 2022-01-05 /pmc/articles/PMC8766983/ /pubmed/35071368 http://dx.doi.org/10.3389/fcvm.2021.809689 Text en Copyright © 2022 Liao, Jiang, Su, Bi, Li, Li, Yang, Zhang and Xie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Liao, Zi-Qi
Jiang, Yi-Nong
Su, Zhuo-Lin
Bi, Hai-Lian
Li, Jia-Tian
Li, Cheng-Lin
Yang, Xiao-Lei
Zhang, Ying
Xie, Xin
Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway
title Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway
title_full Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway
title_fullStr Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway
title_full_unstemmed Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway
title_short Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway
title_sort rutaecarpine inhibits doxorubicin-induced oxidative stress and apoptosis by activating akt signaling pathway
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766983/
https://www.ncbi.nlm.nih.gov/pubmed/35071368
http://dx.doi.org/10.3389/fcvm.2021.809689
work_keys_str_mv AT liaoziqi rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway
AT jiangyinong rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway
AT suzhuolin rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway
AT bihailian rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway
AT lijiatian rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway
AT lichenglin rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway
AT yangxiaolei rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway
AT zhangying rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway
AT xiexin rutaecarpineinhibitsdoxorubicininducedoxidativestressandapoptosisbyactivatingaktsignalingpathway